CLINICAL_TRIALS
trial_result
· 2014-04-02
Clinical Trial Update: TMC207-TiDP13-C117: Interaction Study in Human Immunodeficiency Virus-type 1 (HIV-1) Infected Patients With Nevirapine (NVP) [Phase 1]
Summary
Phase 1 study evaluating potential drug–drug interaction between TMC207-TiDP13-C117 and nevirapine in HIV-1-infected patients; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tibotec BVBA | Conditions: HIV Infections | Phase 1 | Status: COMPLETED